Clinical trial · no report yet · Phase 2
LAVA-CRLM
Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial
- NCT03654131 ↗
- Active not recruiting
- Copenhagen University Hospital, Rigshospitalet
- 7 commentary sources found
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built. Commentary is thin so far, so the report would be short.
| Channel | Found | |
|---|---|---|
| X threads | 7 |
The trial
ClinicalTrials.gov- Official title
- Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver - a Randomized Phase II Trail
- Phase
- Phase 2
- Status
- Active not recruiting
- Conditions
- Colorectal Carcinoma; Liver Metastases
- Interventions
- MWA; SBRT
- Arms
- MWA · Active comparator
- SBRT · Active comparator
- Enrollment
- 100
- Primary outcomes
- Freedom from local lesion progression (analyzed on patient-level)
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
- Start
- Jul 25, 2018
- Primary completion
- Jan 1, 2026
- Results posted
- No
- Registry record
- NCT03654131 · updated Mar 19, 2026
Publications
linked from the registry- Risumlund SL, Stick LB, Appelt A, Vogelius IR, Nyhuus B, Schultz NA, Penninga L, van Overeem Felter M, Josipovic M, Larsen PN. Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial. Lancet Reg Health Eur. 2026 Sep 25;71:101879. doi: 10.1016/j.lanepe.2026.101879. eCollection 2026 Dec. PubMed 42829779